133 related articles for article (PubMed ID: 30981510)
1. Structural basis for efonidipine block of a voltage-gated Ca
Xu F; Xiong W; Huang Y; Shen J; Zhou D; Tang L
Biochem Biophys Res Commun; 2019 Jun; 513(3):631-634. PubMed ID: 30981510
[TBL] [Abstract][Full Text] [Related]
2. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
3. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
[TBL] [Abstract][Full Text] [Related]
4. A selective T-type Ca2+ channel blocker R(-) efonidipine.
Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
[TBL] [Abstract][Full Text] [Related]
5. The Ca(2+) channel inhibitor efonidipine decreases voltage-dependent K(+) channel activity in rabbit coronary arterial smooth muscle cells.
Park MH; Son YK; Hong DH; Choi IW; Kim DJ; Lee H; Bang H; Na SH; Li H; Jo SH; Park WS
Vascul Pharmacol; 2013; 59(3-4):90-5. PubMed ID: 23876554
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
7. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis for Diltiazem Block of a Voltage-Gated Ca
Tang L; Gamal El-Din TM; Lenaeus MJ; Zheng N; Catterall WA
Mol Pharmacol; 2019 Oct; 96(4):485-492. PubMed ID: 31391290
[TBL] [Abstract][Full Text] [Related]
9. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for inhibition of a voltage-gated Ca
Tang L; Gamal El-Din TM; Swanson TM; Pryde DC; Scheuer T; Zheng N; Catterall WA
Nature; 2016 Sep; 537(7618):117-121. PubMed ID: 27556947
[TBL] [Abstract][Full Text] [Related]
11. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
[TBL] [Abstract][Full Text] [Related]
12. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Nakano N; Ishimitsu T; Takahashi T; Inada H; Okamura A; Ohba S; Matsuoka H
Int Heart J; 2010 May; 51(3):188-92. PubMed ID: 20558909
[TBL] [Abstract][Full Text] [Related]
13. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
14. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
[TBL] [Abstract][Full Text] [Related]
15. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
Tanaka H; Komikado C; Shimada H; Takeda K; Namekata I; Kawanishi T; Shigenobu K
J Pharmacol Sci; 2004 Dec; 96(4):499-501. PubMed ID: 15599089
[TBL] [Abstract][Full Text] [Related]
16. Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes.
Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
Life Sci; 2000 Dec; 68(3):345-51. PubMed ID: 11191650
[TBL] [Abstract][Full Text] [Related]
17. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
[TBL] [Abstract][Full Text] [Related]
19. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
Perez-Reyes E; Van Deusen AL; Vitko I
J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y
J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
